Transforming growth factor β-induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2306-2311

  Tsutsui, Naohisa ^a,b   Kamiyama, Tsuneo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CYTOKINE ANTIBODY; GAMMA INTERFERON; NITRIC OXIDE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; HELPER CELL; MALARIA; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032929406     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2306-2311.1999     Document Type: Article

References (42)

1. Barral, A., M. Barral-Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik, and S. G. Reed. 1993. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Nat. Acad. Sci. USA 90:3442-3446.
2. Boutard, V., R. Havouls, B. Fouqueray, C. Philippe, J.-P. Moulinoux, and L. Baud. 1995. Transforming growth factor-β stimulates arginase activity in macrophages. Implication for the regulation of macrophage cytotoxicity. J. Immunol. 155:2077-2084.
3. Cerwenka, A., D. Bevec, O. Majdic, W. Knapp, and W. Holter. 1994. TGF-β1 is a potent inducer of human effector T cells. J. Immunol. 153:4367-4377.
4. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
5. Codias, E. K., J. E. Rutter, T. J. Fleming, and T. R. Malek. 1994. Down-regulation of IL-12 production by activation of T cells through Ly-6A/E. J. Immunol. 153:2394-2406.
6. Cox, F. E. G. 1988. Major animal models in malaria research: rodent, p. 1503-1543. In W. H. Wernsdorfer, and I. McGregor (ed.), Malaria. Principles and practice of malariology, vol. 2. Churchill Livingstone, Edinburgh, United Kingdom.
7. Cross, C. E., and J. Langhorne. 1998. Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice. Exp. Parasitol. 90:220-229.
8. Danielpour, D., K. L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn. 1989. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β 1 and TGF-β 2) secreted by cells in culture. J. Cell. Physiol. 138:79-86.
9. Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton, J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn, and D. V. Goeddel. 1985. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705.
10. Fortin, A., A. Belouchi, M. F. Tam, L. Cardon, E. Skamene, M. M. Stevenson, and P. Gros. 1997. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat. Genet. 17:382-383.
11. Fried, M., R. O. Muga, A. O. Misore, and P. E. Duffy. 1998. Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J. Immunol. 160:2523-2530.
12. Gazzinelli, R. T., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cereberal toxoplasmosis is induced by in vitro neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
13. + T cells stimulated by Plasmodium falciparum. Parasite Immunol. 17:413-423.
14. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P. H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon-gamma can prevent experimental cerebral malaria and its associated over-production of tumor necrosis factor. Proc. Nat. Acad. Sci. USA 86:5572-5574.
15. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
16. Haagmans, B. L. K. J. Teerds, A. J. M. van den Eijnden-van Raaij, M. C. Horzinek, and V. E. C. J. Schijns. 1997. Transforming growth factor β production during rat cytomegalovirus infection. J. Gen. Virol. 78:205-213.
17. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Stricter. 1996. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryplococcus neoformans. J. Immunol. 157:4529-4536.
18. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. Remington. 1995. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994-1000.
19. James, S. L. 1995. Role of nitric oxide in parasitic infections. Microbiol. Rev. 59:533-547.
20. Kamiyama, T., M. Tatsumi, J. Matsubara, Y. Yamamoto, G. Cortez, Z. Rubio, and H. Fujii. 1987. Manifestation of cerebral malaria-like symptoms in WM/Ms rats infected with Plasmodium berghei strain NK65. J. Parasitol. 73:1138-1145.
21. + T cells to Plasmodium chabaudi chabaudi. Immunol. Rev. 112:71-94.
22. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 6:137-161.
23. Meding, S. J., S. C. Cheng, B. Simon-Haarhaus, and J. Langhorne. 1990. Role of gamma interferon during infection with Plasmodium chabaudi chabaudi. Infect. Immun. 58:3671-3678.
24. Miller, L. H. 1988. Genetically determined human resistance factors, p. 487-500. In W. H. Wernsdorfer and I. McGregor (ed.), Malaria. Principles and practice of malariology, vol. 1. Churchill Livingstone, Edinburgh, United Kingdom.
25. Miyazono, K., P. T. Dijke, H. Ichijo, and C.-H. Heldin. 1994. Receptors for transforming growth factor-β. Adv. Immunol. 55:181-220.
26. Murphy, E., S. Hieny, A. Sher, and A. O'Garra. 1993. Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J. Immunol. Methods. 162:211-223.
27. Omer, F. M., and E. M. Riley. 1998. Transforming growth factor production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 188:39-48.
28. Panek, R. B., and E. N. Benveniste. 1995. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-γ, TNF-α, and TGF-β. J. Immunol. 154:2846-2854.
29. Roberts, A. B., and M. B. Sporn. 1990. The transforming growth factor-βs, p. 419. In M. B. Sporn and A. B. Roberts (ed.), Peptide growth factors and their receptors. Springer-Verlag, Berlin, Germany.
30. Rockett, K. A., M. M. Awburn, E. J. Rockett, W. B. Cowden, and I. A. Clark. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:243-249.
31. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchierl, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
32. Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Rude, and T. Germann. 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and Interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793-798.
33. Silva, J. S., D. R. Twardzik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J. Exp. Med. 174:539-545.
34. Stevenson, M. M., J. J. Lyanga, and E. Skamene. 1982. Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect. Immun. 38: 80-88.
35. Stevenson, M. M., M. F. Tam, and M. E. Nowotarsi. 1990. Role of interferon-γ and tumor necrosis factor in host resistance to Plasmodium chabaudi AS. Immunol. Lett. 25:115-122.
36. Tsutsui, N., and T. Kamiyama. 1998. Suppression of in vitro IFN-γ production by spleen cells of Plasmodium chabaudi-infected C57BL/10 mice exposed to dexamethasone at a low dose. Int. J. Immunopharmacol. 20:141-152.
37. Wahlgren, M., J. S. Abrams, V. Fernandez, M. T. Bejarano, M. Azuma, M. Torii, M. Aikawa, and R. J. Howard. 1995. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-β, IL-1RA, IL-6, IL-8, IL-10, TGFβ, TNFα, G-CSF, GM-CSF). Scand. J. Immunol. 42:626-636.
38. Warwick-Davies, J., D. B. Lowrie, and P. J. Cole. 1995. Selective deactivation of human monocyte functions by TGF-β. J. Immunol. 155:3186-3193.
39. Wenisch, C., B. Parschalk, H. Burgmann, S. Looareesuwan, and W. Graninger. 1995. Decreased serum levels of TGF-β1 in patients with acute Plasmodium falciparum malaria. J. Clin. Immunol. 15:69-73.
40. Whittall, J. T. D., and R. M. E. Pirkhouse. 1997. Changes in swine macrophage phenotype after infection with African swine fever virus: cytokine production and responsiveness to interferon-γ and lipopolysaccharide. Immunology 91:444-449.
41. Yap, G. S., P. Jacobs, and M. M. Stevenson. 1994. Th cell regulation of host resistance to blood-stage Plasmodium chabaudi AS. Res. Immunol. 145:419-422.
42. Zhang, L., and R. L. Tarleton. 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26:102-109.